Aurora Spine Announces the Resignation of Board Director James Snow
Rhea-AI Summary
Aurora Spine (OTCQB: ASAPF) announced that James Snow, a board member since 2012, has resigned from the Board of Directors to become the company's Regulatory Affairs and Quality Assurance Manager. Snow, who brings over 20 years of medical device experience in regulatory affairs and quality, will focus on ensuring compliance requirements are met and exceeded.
The transition marks Snow's shift from a strategic to an operational role, where he will leverage his industry expertise to drive quality and compliance across Aurora's expanding innovative product portfolio. The company, which specializes in designing and manufacturing innovative medical devices for spinal surgery outcomes, views this internal movement as strengthening their operational capabilities.
Positive
- Internal promotion maintains continuity and institutional knowledge
- Addition of 20+ years regulatory affairs expertise to operational management
- Strengthened quality and compliance oversight for product portfolio
Negative
- Loss of long-standing board member since 2012
- Need to fill board vacancy
News Market Reaction
On the day this news was published, ASAPF gained 3.37%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
CARLSBAD, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that James Snow, a board member for Aurora Spine since its inception in 2012, has resigned from the Aurora Spine Board of Directors to take on the role of Regulatory Affairs and Quality Assurance Manager for the Company. Mr. Snow will use his 20+ years of medical device experience in regulatory affairs and quality to ensure Aurora Spine meets and exceeds all compliance requirements it has in this area.
“We are very happy to announce that Jim Snow, a long-standing member of our Board of Directors, will be taking a more active role within the Company,” said Trent Northcutt, President and CEO of Aurora Spine. “Jim has been an invaluable contributor to our mission and vision, and we are excited to now benefit from his deep industry expertise and leadership on a full-time basis. His transition from Board Member to a key operational role underscores his belief in Aurora’s future, and we couldn’t be more confident in the impact he’ll make in driving quality and compliance across our expanding innovative product portfolio.”
David Rosenkrantz, Chairman of the Board at Aurora Spine, added, “Jim’s dedication to Aurora has always gone beyond boardroom discussions. Jim’s decision to join the team in an operational capacity demonstrates his commitment and passion for our company and the incredible potential he sees in our technologies.”
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant and pain care markets through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
FAQ
Why did James Snow resign from Aurora Spine's (ASAPF) Board of Directors in April 2025?
How long was James Snow on Aurora Spine's (ASAPF) Board before his resignation?
What will be James Snow's new role at Aurora Spine (ASAPF)?
What experience does James Snow bring to his new position at Aurora Spine (ASAPF)?
